Exact Sciences Corporation
EXAS
$103.75
-$0.19-0.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.25B | 3.08B | 2.94B | 2.83B | 2.76B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.25B | 3.08B | 2.94B | 2.83B | 2.76B |
| Cost of Revenue | 984.24M | 942.51M | 892.87M | 855.19M | 840.15M |
| Gross Profit | 2.26B | 2.14B | 2.05B | 1.97B | 1.92B |
| SG&A Expenses | 1.90B | 1.83B | 1.77B | 1.72B | 1.68B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.41B | 3.20B | 3.08B | 3.01B | 2.95B |
| Operating Income | -161.22M | -121.49M | -138.98M | -176.89M | -191.79M |
| Income Before Tax | -203.89M | -994.77M | -1.01B | -1.03B | -1.04B |
| Income Tax Expenses | 4.06M | -8.19M | -9.22M | -8.89M | -7.30M |
| Earnings from Continuing Operations | -207.95 | -986.58 | -1.01K | -1.02K | -1.03K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -207.95M | -986.58M | -1.01B | -1.02B | -1.03B |
| EBIT | -161.22M | -121.49M | -138.98M | -176.89M | -191.79M |
| EBITDA | 60.36M | 96.88M | 78.28M | 38.09M | 23.07M |
| EPS Basic | -1.10 | -5.32 | -5.42 | -5.50 | -5.56 |
| Normalized Basic EPS | -0.53 | -0.39 | -0.47 | -0.60 | -0.65 |
| EPS Diluted | -1.10 | -5.32 | -5.42 | -5.50 | -5.56 |
| Normalized Diluted EPS | -0.53 | -0.39 | -0.47 | -0.60 | -0.65 |
| Average Basic Shares Outstanding | 754.72M | 750.29M | 745.82M | 741.23M | 736.77M |
| Average Diluted Shares Outstanding | 754.72M | 750.29M | 745.82M | 741.23M | 736.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |